Explore the Risk Factors for Antenatal Mental Disorders in Pregnant Women With Hyperglycemia
1 other identifier
observational
635
0 countries
N/A
Brief Summary
This study aims to investigate the current situation and risk factors of adverse mental disorders in pregnant women with hyperglycemia. it could include any of the following: 18-45 years old pregnant women with hyperglycemia. The main question is to answer the risk factor for antenatal mental disorder. participants need to complete a self-report questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
June 4, 2025
May 1, 2025
11 months
April 22, 2025
May 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patient health questionnaire -9 (PHQ-9) score
In the first, second and third trimesters, due to the government's policy, all pregnancies need to complete a EDSS if they want. When the pregnancies were diagnosed with hyperglycemia, a consent form was sent to them. After getting consent from them, researchers will retrospectively collect their medical records and EDSS scores in the government system when the participants were administrated in hospital to deliver the baby. the interpretation of PHQ-9: Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.
Participants were administered in the hospital to deliver the baby.
Secondary Outcomes (1)
Generalized Anxiety Disorder-7 scale score (GAD-7)
Participants were administered in the hospital to deliver the baby.
Study Arms (1)
pregnant women with hyperglycemia
Inclusion criteria: ① Pregnant women were confirmed as having gestational diabetes through biochemical examinations and glucose tolerance tests, etc. ② Possess the abilities of listening, speaking, reading, writing and comprehension, and be capable of effective communication; ③ Age: 18-45 years old (including 18 and 45 years old); ④ Informed consent and voluntary participation in the research; ⑤ Gestational age: 28 to 37 weeks (including 28 weeks but excluding 37 weeks). Exclusion criteria: ① Abnormal fetuses and multiple pregnancies; ② Other pregnancy complications and comorbidities, such as heart disease, preeclampsia, liver disease, etc. ③ There is a history of mental illness or mental disorders in the past. ④ Those who are unable to communicate effectively by using listening, speaking, reading and writing skills; ⑤ Patients with diabetes mellitus complicated with pregnancy; ⑥ Those who use psychotropic or neurotropic drugs.
Eligibility Criteria
Participants should follow inclusive and exclusive criteria.
You may qualify if:
- The pregnant woman was confirmed to have gestational diabetes through biochemical tests and glucose tolerance tests, etc.
- Possess the abilities of listening, speaking, reading, writing and comprehension, and be capable of effective communication;
- Age: 18-45 years old (including 18 and 45 years old);
- informed consent and voluntary participation in the research;
- Gestational age: 28 to 37 weeks (including 28 weeks but excluding 37 weeks).
You may not qualify if:
- Abnormal fetuses, multiple pregnancies;
- Other pregnancy complications and comorbidities, such as heart disease, preeclampsia, liver disease, etc.
- There is a history of mental illness or mental disorders in the past.
- Those who are unable to communicate effectively by using listening, speaking, reading and writing skills;
- Patients with diabetes mellitus complicated with pregnancy;
- Those who use psychotropic or neurotropic drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Delanerolle G, Phiri P, Zeng Y, Marston K, Tempest N, Busuulwa P, Shetty A, Goodison W, Muniraman H, Duffy G, Elliot K, Maclean A, Majumder K, Hirsch M, Rathod S, Raymont V, Shi JQ, Hapangama DK. A systematic review and meta-analysis of gestational diabetes mellitus and mental health among BAME populations. EClinicalMedicine. 2021 Jul 14;38:101016. doi: 10.1016/j.eclinm.2021.101016. eCollection 2021 Aug.
PMID: 34308317BACKGROUNDDOI:10.16766/j.cnki.issn.1674-4152.003467.
BACKGROUNDThiele GA, Ryan DM, Oberlander TF, Hanley GE. Preconception mental health and the relationship between antenatal depression or anxiety and gestational diabetes mellitus: a population-based cohort study. BMC Pregnancy Childbirth. 2022 Aug 31;22(1):670. doi: 10.1186/s12884-022-05002-5.
PMID: 36045319BACKGROUNDSchmitt A, Bendig E, Baumeister H, Hermanns N, Kulzer B. Associations of depression and diabetes distress with self-management behavior and glycemic control. Health Psychol. 2021 Feb;40(2):113-124. doi: 10.1037/hea0001037. Epub 2020 Nov 30.
PMID: 33252963BACKGROUNDRiggin L. Association Between Gestational Diabetes and Mental Illness. Can J Diabetes. 2020 Aug;44(6):566-571.e3. doi: 10.1016/j.jcjd.2020.06.014. Epub 2020 Jun 22.
PMID: 32792108BACKGROUNDhttps://www.mdpi.com/1660-4601/17/11/3767.
BACKGROUNDMazumder T, Akter E, Rahman SM, Islam MT, Talukder MR. Prevalence and Risk Factors of Gestational Diabetes Mellitus in Bangladesh: Findings from Demographic Health Survey 2017-2018. Int J Environ Res Public Health. 2022 Feb 23;19(5):2583. doi: 10.3390/ijerph19052583.
PMID: 35270274BACKGROUNDYe W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022 May 25;377:e067946. doi: 10.1136/bmj-2021-067946.
PMID: 35613728BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
April 22, 2025
First Posted
June 4, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
protocol